I agree, concise, straight to the point.
Top management team. Risks are understood with regards trials and being a single product keeps the team focused also. Drug is safe. Manufacturing/commercialisation risks will be understood down the track.
It's a low key, quality stock with a tight register and it's going to go up in multiples. I'm buying.
- Forums
- ASX - By Stock
- Ann: Quarterly Report and Appendix 4C with appendix
I agree, concise, straight to the point.Top management team....
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
0.013(16.9%) |
Mkt cap ! $6.763M |
Open | High | Low | Value | Volume |
8.5¢ | 9.0¢ | 8.5¢ | $12.10K | 134.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 125000 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 2750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125000 | 0.085 |
1 | 84879 | 0.076 |
2 | 11693 | 0.075 |
1 | 500000 | 0.040 |
1 | 70001 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 2750 | 1 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 15.57pm 28/10/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |